Author name: Mirror Review

The deal would enable healthcare professionals to deliver better services with enhanced patient engagement. J2 Interactive, an award-winning healthcare IT consulting firm has acquired Boston-based Saxa Solutions. The acquisition is closed on December 1, 2018, and Saxa will continue to operate as ‘Saxa Solutions, a J2 company’ for a brief time before merging its brand […]

The pre-clinical data by Editas Medicine supports novel approach for treatment of sickle cell disease and beta-thalassemia. Editas Medicine, Inc., a leading genome editing company, recently shared outcomes from experiments to demonstrate expanded CRISPR genome editing strategies in hematopoietic stem cells for the treatment of sickle cell disease and beta-thalassemia. In these experiments, the Cambridge,

For CVS, the Aetna deal is a transformative moment in health care that will enable it to make the industry less confusing and difficult to navigate. CVS Health, an American retail pharmacy and health care company have announced to acquire Aetna in December 2017, and the deal is been completed recently post receiving various approvals.

With this acquisition, Genentech will obtain full rights to Jecure’s entire preclinical portfolio of NLRP3 inhibitors. Swiss drugmaker Roche is buying Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases. According to a definitive agreement, Jecure will be acquired by Genentech, which is a member of the Roche Group.